I first read up on the company in January of 05.I liked the markets they were suppyling to then,and they also had some great future growth speculation.Not going to lie it was also at .94 when I bought it in January of 2005 an was my first ever pick but none the less I did my homework,only to forget about it as I was in need of funding elsewhere lol till early 07 an now I'm gladly still holding hoping for a split and some growth in the upcoming future.Finally gettin the reconition it deserves. Still growing strong I see 3.00 in this companies future!!Had a slight pull back on tuesday which was expected as it now has to digest it's latest jump.I see new people adding it to portfolios every day, it's trading above or around it's 52 week high now but I still say it's a strong buy at least b4 gettin close to $3.00.It's growth in the past two years in price is strong.Nothing but good things from here folks! Going through a slight pull back guess theres been a few sells offs along with it trying to digest its lates leap.(sigh) still boasting great growth potential.(April 19th)

Buying this as an option trying it out.It's costing me $6.00 cheap speculation.All though theres nice dividends on DUK so I'm expecting it to outperform again,after a brief posible pullback.I don't have access to a decent amount of funding at the moment so $6.00 is fine for the chance of a decent return in the hundreds okay. Option bought Tuesday April 17th.looking to see this stock climb with the recent clean energy(green day) news.Option is set to expire May 19th symbol .DUKEX with a strike price of $22.50 first option I've ever traded like I said before it's just a cheap speculation. I also stumbled across another energy stock I can't post trading at around .05 right around it's low.It's symbol is NNYR cheap stock that could spike off the recent green day talks.Followed up with a a lil homework I find it a cheap buy great growth potential.Picked up some shares.

This company has it's hands on the right technology.It even gave some away.Does work with the good type of F.L.O systems lol if u get me haha (Fast Lane Option)in your airports not only that they work extensively with the latest forms of security identifications eyes/face/finger/card identifing.Companies supplied to even include Ho Ho Homeland security but a lass they were delisted off nasdaq wtf is going on here?I had this labled as a hate pick.I'm going with my inital gut of long speculation of it being a good buy.An taking it as a time to buy in. Bought in Tuesday April17th:Hoping with the recent addition of the F.L.O to be kicking off shortly to see a nice spike.I feel this poor company needs some more good news,an some help but long ago I had faith an still do. Just in case anyone else interested in this company didn't know the partners involved in the invention/use of the F.L.O. they include some names like.Microsoft ,JPMorgan Chase,Johnson Controls,The Paradies Shops,Expedia Corporate Travel and ID technology

This is a company I'm following after some research and giving it a recent recommendation to someone for a long term growth stock.The company looks to be heading in the right direction with it's research in autoimmune dieseases.It's marked as an underperformer sadly an just seems to be dancing around the price I recomendded it if not lower.(sigh) They seem to be taking strides towards cures for herpes, malaria, viral encephalitis and cancer.With advancements as well as intrests in these areas I felt this to be a posible breakout. Heres some info on the companies lead product. CEL-SCI Corporation's lead product, Multikine®, is being developed for the treatment of cancer.The concept behind Multikine is to harness the power of the immune system against cancer. Multikine is a biologic comprised of cytokines that stimulate the human immune system to overcome tumor tolerance. Multikine demonstrated a 33% increase in the median overall survival at 3 ½ years post-surgery in head & neck cancer patients when administered as a local injection, outpatient, prior to standard first-line therapy, in Phase II trials. Local/regional control also improved. The patients were all diagnosed with advanced untreated primary tumors. Multikine was cleared for Phase III clinical trials in the US (January 2007) and previously in Canada. The study will enroll ~800 advanced primary head & neck cancer patients. Multikine is patented, tumor non-specific, and has shown clinical benefit in other solid tumor types. No serious adverse events (SAEs) related to Multikine have been reported in 200+ Multikine treated patients. Multikine’s mechanism of action is completely different than other cancer therapies; therefore, Multikine should be additive to other therapies and result in further clinical benefit, without additional toxicity. (Journal of Clinical Oncology, May 2005). Multikine also renders cancer cells much more susceptible to follow-on radiation therapy. (The Laryngoscope, December 2003). Other potential indications for Multikine include cervical dysplasia, breast cancer, melanoma and prostate cancer. Another product is: L.E.A.P.S.TM is a patented, T-cell modulation, peptide epitope delivery technology that enables CEL-SCI to design and synthesize proprietary peptide immunogens. L.E.A.P.S. compounds consist of a small T-cell binding peptide ligand linked with a disease-associated peptide antigen. This new technology has been shown in several animal models to preferentially direct immune response to a cellular (e.g. T-cell), humoral (antibody) or mixed pathway. Any disease for which antigenic epitope sequences have been identified, such as infectious diseases, cancer, autoimmune diseases, allergic asthma and allergy, and select CNS diseases (e.g., Alzheimer’s) are potential candidates for this technology platform. The leading product candidate that has been developed from this technology is the CEL-1000 peptide. This peptide has shown protection in animals against malaria, herpes and cancer. This data was recently presented at a scientific meeting by U.S. Navy researchers. Most of the L.E.A.P.S. research and development is supported by grants. If it underperforms now I feel it's even more of a buy I'm watching for a steady balance as I may pick it up for myself as well.I all ready hold a bio tech company, I know an I do feel strongly on diversifying,still I may add it. I have other sector picks as well which I will post soon to track.Moving to slow to really get a handle on this company.Needs a little boost with some new news in the medical market (sigh).

Heres one that was recomendded to me by my girlfriend actually she wanted to enroll in cnbc's contest an ride this one lol.After her dissapointment of not being able to we settled on adding it to a watch list looking for it to drop back some an hopefully buy.I fear we may have missed the boat as it's moving ahead now,I went with my stem cell pick insted at the time seeing a better bang for the buck.But with diversification in my future this is one to keep on my radar.I feel stronger on HYEG though. This was a quick buck when it was lower,had no where to go but up an thats exactlly what it did.It won't let me post HYEG so heres some info. HYEG is one(Hydrogen Engine Center INC) I'm watching in hope to diversify my portfolio with boasting both short/long term gains.I feel strongly about wind/water energy for the future.This company is trading well near it's low,with a lot of room to go up.I feel not to just the energy companies here are strong but the companies developing parts for these companies all stand to profit as the world struggles for new ways of power.I spotted it at $3.00 I think,wanted to see it pull back to around where it's at now hope to execute a buy soon maybe of both.

This is a company I've been watching for a while,It was a cnbc contest pick I've made some strong gains off it I picked it after reading up on arxx.I was looking at some defense plays this one has performed better then arxx as of late more steady uptrend at least.I know they are somewhat different sectors but both do involve themselves in some Aerospace technology.In my recent blog I spoke about congress's outlook on carbon especially C02,I'm wondering if this company is taking steps in producing a cleaner way for releasing carbon could be the way it took a lil beating in after hours but still for the time i've followed this company I've seen nothing but outperforming.Heres a little info. SGL Carbon AG (SGL) is the producer of carbon and graphite products, used primarily in electric arc furnace steel production and aluminum smelting. It also manufactures natural and synthetic graphite products for a variety of industrial applications worldwide. The SGL Carbon Group operates in various business areas: carbon and graphite (CG), specialties (S) and SGL technologies (ST). CG manufactures and markets graphite electrodes, and certain carbon and graphite products (carbon electrodes, cathodes and furnace linings). S manufactures and markets graphite products with a variety of applications and for a large number of industrial sectors, including semiconductors, energy management, tool manufacturing, ferrous and non-ferrous metallurgy, high-temperature processes, automotive, glass and ceramics. ST manufactures carbon fibers, aerospace and industrial composites, expanded graphite (including yarns and fabrics), carbon ceramic brake discs and fuel cell components. I know we are in earnings season,but if a company like ths can take a few punches fall back to a strong buy point then as all this political bs passes over it may get the chance to run again.I'm not saying it's all this company im sure other energy companies will take a hit just saying,there could be hidden growth after these discussion pass by.We can't help the destruction of our world to our growing industry but at least maybe we can try to clean it up some.

Not a pick of mine!! Someone came to me asking me to watch this companies stock.They stumbled across some shares as a gift I guess years ago when they where worth more money (sigh) Now they are looking to get out an seeking a good time,like round $2.00 range (sigh) This company has pending lawsuit/s which could drag shares down some (buy point eh?) Lawsuit verdict depending could an more then likely have an effect on this stocks price.It seems like they could head in the right direction just could end up underperforming through it's troubled times.All I can say is it needs a balance out first then a speculation from there.None the less I said I'd watch it. Slow moving needs to get out of it's lawsuits with verdicts in it's favor followed by a quick sell off lol.Seems to slowly be taking strides to move on up maybe it's coming off a correction from the pending law suit.Verdict may send it right back into one though.

Well I couldn't put NWY on the hate list an say I like COH better without putting it up lol.I've been tracking this company since the start of the cnbc contest hard it marked for a nice spring breakout.It's had almost as nice of a run as CSG sorry wrong sector just an example in the time frame, or even say DKS as well.I still feel strongly on this pick through the summer and into the brink of fall.I'd like look to pick it back up after that around the winter thaw.